Skip to content
March 13, 2024

Equity.Guru

Investment information for the new generation

Search

Vivo Cannabis

[image credit: https://weedit.network/] The overall health of the cannabis sector still isn’t good. Think crypto and blockchain in the winter of 2018 and you get an idea of what…
In this episode, we take a look at 4 Canadian cannabis stocks with potential. High Tide Cannabis (HITI.V), Heritage Cannabis Holding (CANN.C), Tetra Bio-Pharma (TBP.T) and VIVO Cannabis Inc.,…
What to say about Cannabis stocks. You give us some hope, and then pull the rug from under us. If you are a member of Equity Guru’s Free Trading…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Vivo Cannabis’ (VIVO.T) Vanluven facility in Napanee, Ontario, landed its European Union good manufacturing practices (EU-GMP) certification today, according to a press release. The certification gives Vivo the nod…
Way way waaaay back, when Equity.Guru was a young pup and the cannabis industry was still being built on fumes of promise, Vivo Cannabis (VIVO.V) – formerly AbCann –…
VIVO Cannabis (VIVO.V) has selected Dr. Richa Love, the medical director at their subsidiary, Harvest Medicine, to serve as their company’s chief medical officer. Love has built a reputation…
VIVO Cannabis (VIVO.V) is closing 2018 strong with industry accolades and an impressive financial performance in Q3. Firstly, the company’s subsidiary, Canna Farms, was voted the ‘Top Reviewed Licensed Producer…
Licensed producer VIVO Cannabis (VIVO.V) is a serious player in the Canadian cannabis sector which isn’t getting the attention it deserves. The company’s $300 million valuation belies the strategic…
Harvest Medicine, a subsidiary of VIVO Cannabis (VIVO.V), has just released a new telemedicine app which could help bridge the long-troublesome gap between cannabis companies and insurance providers. In…